[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$mnkd](/topic/$mnkd)

### Sentiment: XXX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mnkd/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mnkd/time-series/sentiment.tsv)  
**Current Value**: XXX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XXX% +25%  
**1-Year High**: XXX% on 2025-04-28  
**1-Year Low**: XX% on 2025-10-07  

**Most Supportive Themes**
- **Positive Developments for Afrezza:** (65%) Enthusiasm for MannKind's FDA acceptance of sBLA for Afrezza inhaled insulin for children and teens, with potential for it to become the first inhaled insulin option for pediatric diabetes.
  
**Most Critical Themes**
- **Market Volatility:** (35%)  Concerns about price fluctuations and market uncertainty.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | X        | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | X        | X% |